Loading

wait a moment

Clinical presentation of patients with aseptic meningitis: Results — Anti-infective use

Further analysis (linear regression using the same characteristics as above) of the empirically treated group demonstrated that age older than 16 years was a determinant in the provision of acyclovir, accounting for 22.6% (n=38) of the variability between the administered Read More

Clinical presentation of patients with aseptic meningitis: Methods

Subsequent to appropriate ethics approval from both institutions, patients seen at Capital District Health Authority (CDHA) (Halifax, Nova Scotia) hospitals or the Izaak Walton Killam (IWK) Hospital (Halifax, Nova Scotia) whose CSF samples were tested for the presence of enterovirus Read More

Clinical presentation of patients with aseptic meningitis: part 2

Enteroviral (EV) meningitis can often present with signs and symptoms that broadly overlap with those of other forms of meningitis. Consequently, patients presenting with EV meningitis are sometimes admitted for observation and treatment until definitive testing can be performed. However, Read More

Clinical presentation of patients with aseptic meningitis: part 1

Clinical presentation of patients with aseptic meningitis factors influencing treatment and hospitalization, and consequences of enterovirus cerebrospinal fluid polymerase chain reaction testing. Introduction: Clinical and laboratory features of enteroviral meningitis may overlap with those of bacterial meningitis. In the present Read More

Pages: Prev 1 2 3 ... 67 68 69 70 71 72 73 74 75 76 77 Next